Literature DB >> 12530950

Vascular liver diseases.

Laurie D DeLeve1.   

Abstract

This article reviews the primary circulatory liver diseases, which include Budd-Chiari syndrome, obstruction of the hepatic portion of the inferior vena cava, portal vein thrombosis, sinusoidal obstruction syndrome (veno-occlusive disease), nodular regenerative hyperplasia, and peliosis hepatis. In addition, two systemic cardiovascular diseases that impair hepatic circulation, ischemic hepatitis and congestive hepatopathy, are briefly discussed. A characteristic of the primary circulatory liver diseases is that portal hypertension usually precedes liver dysfunction; however, this is not the case with the primary parenchymal liver diseases, in which liver dysfunction always progresses before portal hypertension is manifested. Significant overlap exists among the diseases and risk factors that predispose patients to the primary circulatory liver diseases, though the pathogenesis of individual diseases varies.

Entities:  

Mesh:

Year:  2003        PMID: 12530950     DOI: 10.1007/s11894-003-0011-0

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  49 in total

1.  Veno-occlusive disease of the liver after busulfan, melphalan, and thiotepa conditioning therapy: incidence, risk factors, and outcome.

Authors:  J L Lee; T Gooley; W Bensinger; K Schiffman; G B McDonald
Journal:  Biol Blood Marrow Transplant       Date:  1999       Impact factor: 5.742

2.  Peliosis hepatis and sinusoidal dilation during infection by the human immunodeficiency virus (HIV). An ultrastructural study.

Authors:  J Y Scoazec; C Marche; P M Girard; J Houtmann; A M Durand-Schneider; A G Saimot; J P Benhamou; G Feldmann
Journal:  Am J Pathol       Date:  1988-04       Impact factor: 4.307

3.  Characterization of a reproducible rat model of hepatic veno-occlusive disease.

Authors:  L D DeLeve; R S McCuskey; X Wang; L Hu; M K McCuskey; R B Epstein; G C Kanel
Journal:  Hepatology       Date:  1999-06       Impact factor: 17.425

Review 4.  A clinical update in polycythemia vera and essential thrombocythemia.

Authors:  A Tefferi; L A Solberg; M N Silverstein
Journal:  Am J Med       Date:  2000-08-01       Impact factor: 4.965

Review 5.  Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules.

Authors:  I R Wanless
Journal:  Hepatology       Date:  1990-05       Impact factor: 17.425

Review 6.  Successful treatment of severe azathioprine-induced hepatic veno-occlusive disease in a kidney-transplanted patient with transjugular intrahepatic portosystemic shunt.

Authors:  D Azoulay; D Castaing; A Lemoine; D Samuel; P Majno; M Reynes; B Charpentier; H Bismuth
Journal:  Clin Nephrol       Date:  1998-08       Impact factor: 0.975

7.  Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis.

Authors:  S Cortelazzo; G Finazzi; M Ruggeri; O Vestri; M Galli; F Rodeghiero; T Barbui
Journal:  N Engl J Med       Date:  1995-04-27       Impact factor: 91.245

8.  Venocclusive disease of the liver after allogeneic bone marrow transplantation in man.

Authors:  G Ganem; M F Saint-Marc Girardin; M Kuentz; C Cordonnier; G Marinello; C Teboul; F Braconnier; J P Vernant; D Dhumeaux; J P Le Bourgeois
Journal:  Int J Radiat Oncol Biol Phys       Date:  1988-05       Impact factor: 7.038

9.  Abdominal visceral peliosis associated with bacillary angiomatosis. Ultrastructural evidence of endothelial destruction by bacilli.

Authors:  S S Leong; R A Cazen; G S Yu; L LeFevre; J W Carson
Journal:  Arch Pathol Lab Med       Date:  1992-08       Impact factor: 5.534

10.  Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: the role of glutathione and relevance to hepatic venoocclusive disease.

Authors:  L D DeLeve; X Wang; J F Kuhlenkamp; N Kaplowitz
Journal:  Hepatology       Date:  1996-03       Impact factor: 17.425

View more
  7 in total

1.  Congenital malformations of the suprahepatic inferior vena cava: an easily overlooked etiology of chronic liver disease with tumor-like nodules.

Authors:  Giovanna Borghi-Scoazec; Pierre Rocca-Zanella; Pierre-Jean Valette; Didier Revel; Olivier Boillot; Christian Trepo; Jean-Yves Scoazec
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

2.  Peliosis hepatis as an early histological finding in idiopathic portal hypertension: A case report.

Authors:  Annalisa Berzigotti; Donatella Magalotti; Paola Zappoli; Cristina Rossi; Francesco Callea; Marco Zoli
Journal:  World J Gastroenterol       Date:  2006-06-14       Impact factor: 5.742

3.  Peliosis Hepatis Complicating Pregnancy: A Rare Entity.

Authors:  Muhammad Osama Butt; Nasir Hassan Luck; Syed Mujahid Hassan; Zaigham Abbas; Muhammed Mubarak
Journal:  J Transl Int Med       Date:  2017-06-30

4.  Angiopoietin-1 causes reversible degradation of the portal microcirculation in mice: implications for treatment of liver disease.

Authors:  Nicole L Ward; Alexandra L Haninec; Paul Van Slyke; John G Sled; Celina Sturk; R Mark Henkelman; Ian R Wanless; Daniel J Dumont
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

5.  Biochemical evidence of mild hepatic dysfunction identifies decompensated heart failure patients with reversible renal dysfunction.

Authors:  Meredith A Brisco; Brian D McCauley; Jennifer Chen; Chirag R Parikh; Jeffrey M Testani
Journal:  J Card Fail       Date:  2013-10-17       Impact factor: 5.712

6.  A 34-year-old man with membranous nephropathy, a rash, meningitis and ocular involvement.

Authors:  Gianni Bellomo; Claudio Verdura; Sandro Venanzi; Paolo Saronio; Mario Timio
Journal:  NDT Plus       Date:  2008-05-06

Review 7.  Role of Chemerin/ChemR23 axis as an emerging therapeutic perspective on obesity-related vascular dysfunction.

Authors:  Yingying Xie; Ling Liu
Journal:  J Transl Med       Date:  2022-03-22       Impact factor: 5.531

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.